These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33236430)

  • 1. Upper airway involvement in pediatric COVID-19.
    Parisi GF; Brindisi G; Indolfi C; Diaferio L; Marchese G; Ghiglioni DG; Zicari AM; Miraglia Del Giudice M
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):85-88. PubMed ID: 33236430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study.
    Gözen ED; Aliyeva C; Tevetoğlu F; Karaali R; Balkan İİ; Yener HM; Özdoğan HA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):169S-173S. PubMed ID: 33236918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 associated anosmia in pediatric patients: subject publications review.
    Lobova OV; Avramenko IV; Shpak II
    Wiad Lek; 2024; 77(1):114-119. PubMed ID: 38431815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.
    Vaira LA; Deiana G; Fois AG; Pirina P; Madeddu G; De Vito A; Babudieri S; Petrocelli M; Serra A; Bussu F; Ligas E; Salzano G; De Riu G
    Head Neck; 2020 Jun; 42(6):1252-1258. PubMed ID: 32342566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for anosmia and ageusia in patients presenting to the emergency department with suspected coronavirus disease 2019 in Saudi Arabia.
    Kentab OY; Ibrahim AAA; Soliman KR; Alanazi M; Alsunaid A; Ababtain A; Alresseeni AI; Algarni A; Aljohani K; Aljahany M
    J Int Med Res; 2022 May; 50(5):3000605221096280. PubMed ID: 35510652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia in pediatric cases.
    Hatipoglu N; Yazici ZM; Palabiyik F; Gulustan F; Sayin I
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110469. PubMed ID: 33120100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: COVID-19 Patient With Chief Complaint of Anosmia and Ageusia; a Unique Perspective on Atypical Symptomatology and Management in the Military.
    Smith LTAC; Hodges CDRJ; Pratt M; Porter IM
    Mil Med; 2020 Dec; 185(11-12):e2176-e2179. PubMed ID: 32776115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anosmia and ageusia as primary symptoms of COVID-19].
    Haldrup M; Johansen MI; Fjaeldstad AW
    Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
    Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
    Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection.
    Gómez-Iglesias P; Porta-Etessam J; Montalvo T; Valls-Carbó A; Gajate V; Matías-Guiu JA; Parejo-Carbonell B; González-García N; Ezpeleta D; Láinez JM; Matías-Guiu J
    Front Public Health; 2020; 8():243. PubMed ID: 32574308
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
    Lee Y; Min P; Lee S; Kim SW
    J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and Characteristics Which Require Attention During COVID-19 Screening at a Port of Entry.
    Song SW; Kim D; Park JY; Lee S
    J Korean Med Sci; 2021 Jan; 36(2):e14. PubMed ID: 33429473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema annulare centrifugum with anosmia and ageusia in a SARS-CoV-2 exposed patient successfully treated with doxycycline.
    Montinari M; Atzori L; Valdevit S; Rongioletti F
    Int J Dermatol; 2021 Mar; 60(3):384-386. PubMed ID: 33368328
    [No Abstract]   [Full Text] [Related]  

  • 18. Photobiomodulation therapy for treatment olfactory and taste dysfunction COVID-19-related: A case report.
    de Souza VB; Ferreira LT; Sene-Fiorese M; Garcia V; Rodrigues TZ; de Aquino Junior AE; Bagnato VS; Panhoca VH
    J Biophotonics; 2022 Aug; 15(8):e202200058. PubMed ID: 35445797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19, anosmia, and ageusia in atopic children.
    Parisi GF; Brindisi G; Indolfi C; Diaferio L; Marchese G; Ghiglioni DG; Zicari AM; Miraglia Del Giudice M
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):99-101. PubMed ID: 35080301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
    PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.